NCT01147198

Brief Summary

Since 2001, Ready to Use Therapeutic Foods (RUTF) are widely used to treat severe malnutrition. Their efficacy and effectiveness were proven in community therapeutic care programs. Recently, the question rose if RUTF would be more effective than enriched flours to treat moderate malnutrition. The purpose of this study is to compare the effectiveness of Ready to Use Food Supplementary-plumpy® and Premix Corn Soy Blend with oil in term of cure rate, weight gain, duration of treatment, morbidity and mortality in the treatment of moderate acute malnutrition. Compare the longer term effect on nutritional status and morbidity (relapse?).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
570

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2007

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2007

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2008

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 22, 2010

Completed
Last Updated

January 24, 2012

Status Verified

March 1, 2007

Enrollment Period

4 months

First QC Date

June 17, 2010

Last Update Submit

January 23, 2012

Conditions

Keywords

ModerateWastingMalnutritionReady to Use FoodFortified Blended Flour

Outcome Measures

Primary Outcomes (1)

  • Recovery

    proportion of children who recovered, defined as WHM\> 85% for two consecutive weeks

    112 days

Secondary Outcomes (3)

  • average weight gain

    112 days

  • Duration of treatment

    112 days

  • Morbidity

    11 months

Study Arms (2)

Ready to Use Supplementary Food

ACTIVE COMPARATOR

Ready to Use Supplementary Food treatment

Dietary Supplement: Ready to Use Supplementary Food

Premix

ACTIVE COMPARATOR

Premix Corn Soy Blend-oil treatment

Dietary Supplement: Premix CSB-oil treatment

Interventions

Children received two Supplementary-plumpy® packages per day (184g) providing 1000 Kcal, 26g (10.4%) protein, 68g (61.2%) fat, and 100% of micronutrient requirements based on the Daily Recommended Nutrient Intake.

Also known as: Supplementary-plumpy®
Ready to Use Supplementary Food
Premix CSB-oil treatmentDIETARY_SUPPLEMENT

Children received 2 kg of premix per week (226g CSB, 37g oil, and 23g sugar / day) providing 1277 Kcal, 40.7g protein (12.7%), 50.6g (35.7%) fat, and 100% of micronutrient according to the DRNI guidelines

Also known as: Corn Soy Blend, Fortified Blended Flours
Premix

Eligibility Criteria

Age6 Months - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • all children aged 6 months to 5 years admitted to SFC outpatient care during the study period
  • WHM between 70-79% (1977 NCHS/WHO standard) without edema
  • approval from the caretaker

You may not qualify if:

  • presence of the following signs: bilateral edema, MUAC\<110 mm , WHM\< 70%(criteria for severe malnutrition), and medical complications necessitating hospitalisation
  • refusal to participate from caretaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Centers run by MSF and MOH

Bo, Bo, Sierra Leone

Location

MeSH Terms

Conditions

Lymphoma, FollicularCachexiaMalnutrition

Condition Hierarchy (Ancestors)

Lymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesWeight LossBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsThinnessNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Pascale Delchevalerie, Msc

    Medecins Sans Frontieres, Netherlands

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 17, 2010

First Posted

June 22, 2010

Study Start

April 1, 2007

Primary Completion

August 1, 2007

Study Completion

April 1, 2008

Last Updated

January 24, 2012

Record last verified: 2007-03

Locations